Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2938 Target Snapshot

Protein kinase C gamma type · SINGLE PROTEIN · Homo sapiens

1,809Compounds
324Assays
1Approved Drugs
1,115.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P05129. Use UniProt P05129 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P05129 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Protein kinase C gamma type as ChEMBL target CHEMBL2938, mapped to UniProt P05129. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Protein kinase C gamma type
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2938
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P05129
Protein kinase C gamma type
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Protein kinase C gamma type is the right protein anchor across sources, using UniProt P05129 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProtein kinase C gamma type
UniProt AccessionP05129
Component TypeProtein
Sequence Length697 aa

Protein kinase C gamma type

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Protein kinase C gamma type, mapped to UniProt P05129. Sequence length is 697 aa.

Mapped IDP05129
Review nameProtein kinase C gamma type
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
4
Phase III
8
Phase II
4
Phase I
Assay Mix

Activity Type Distribution

IC50253.0
KI851.0
KD11.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL337834 9.8 Kd 0.16 Preclinical
CHEMBL2148106 9.42 Ki 0.38 Preclinical
CHEMBL388978 9.27 IC50 0.542 Preclinical
CHEMBL1256416 9.2 Ki 0.63 Preclinical
CHEMBL5175742 9.19 Ki 0.65 Preclinical
CHEMBL2418196 9.16 Ki 0.69 Preclinical
CHEMBL285801 8.92 Ki 1.2 Preclinical
CHEMBL27768 8.92 Kd 1.19 Preclinical
CHEMBL337834 8.82 Ki 1.5 Preclinical
CHEMBL27768 8.8 Ki 1.58 Preclinical
Distribution

pChEMBL Value Distribution

92
5.0
94
5.5
59
6.0
68
6.5
47
7.0
32
7.5
28
8.0
15
8.5
6
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

ENTRECTINIB
CHEMBL1983268
Approved 2019
Assay Landscape

Assay Landscape

324
Total Assays
210
Tested Compounds
3
Assay Types
Binding — 318 assays, 210 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 273 197 6.7
cell-based format 24 5 5.8
assay format 20 4 7.7
cell membrane format 1 4 7.3
Functional — 5 assays, 166 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 5 166 5.9
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine